EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
4.2.1.2 | Acidosis |
30953950 |
Extracellular Acidosis Modulates the Expression of Epithelial-Mesenchymal Transition (EMT) Markers and Adhesion of Epithelial and Tumor Cells. |
causal interaction therapeutic application unassigned |
2 1 0 |
4.2.1.2 | Acquired Immunodeficiency Syndrome |
33058874 |
Post-translational Modifications of Fumarase Regulate its Enzyme Activity and Function in Respiration and the DNA Damage Response. |
causal interaction unassigned |
3 0 |
4.2.1.2 | Acute Kidney Injury |
28094329 |
Fumarase activity: an in vivo and in vitro biomarker for acute kidney injury. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 3 1 |
4.2.1.2 | Adenocarcinoma |
17884296 |
Inactivation of metabolic enzymes by photo-treatment with zinc meta N-methylpyridylporphyrin. |
therapeutic application unassigned |
1 0 |
4.2.1.2 | Adenoma, Oxyphilic |
12844484 |
Mitochondrial complex I is deficient in renal oncocytomas. |
causal interaction diagnostic usage ongoing research unassigned |
4 1 3 0 |
4.2.1.2 | Adenomatous Polyposis Coli |
19509103 |
Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. |
causal interaction diagnostic usage unassigned |
1 1 0 |
4.2.1.2 | Adenomyoma |
30895261 |
MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas. |
causal interaction unassigned |
3 0 |
4.2.1.2 | Adrenocortical Adenoma |
32249909 |
Cardiac Myxoma Caused by Fumarate Hydratase Gene Deletion in Patient With Cortisol-Secreting Adrenocortical Adenoma. |
causal interaction unassigned |
2 0 |
4.2.1.2 | Anemia, Sickle Cell |
21733559 |
Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. |
causal interaction unassigned |
3 0 |
4.2.1.2 | Angiomyolipoma |
33183792 |
Chromophobe renal cell carcinoma: current and controversial issues. |
unassigned |
0 |